Updated Jul 16, 2026
Morales Mallory is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $2K.
Mallory Morales is the Chief Accounting Officer at Immuneering Corp, a biopharmaceutical company focused on drug development for oncologic and neurologic diseases. She has been involved in the company's financial oversight and reporting.
| Role | SVP Finance, CAO |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-10-01 | IMRX | Immuneering Corp | P — Open-market purchase | 300 | $6.39 | $2K |
| 2025-09-15 | IMRX | Immuneering Corp | A — Grant or award | 14.5K | $1.43 | $21K |
Mallory Morales is the Chief Accounting Officer at Immuneering Corp, a biopharmaceutical company focused on drug development for oncologic and neurologic diseases. She has been involved in the company's financial oversight and reporting.…
Recorded transactions: 1 open-market purchases ($2K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Morales Mallory profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.